Difference between revisions of "Hodgkin lymphoma"
Jump to navigation
Jump to search
(→Nodular lymphocyte-predominant HL: +image) |
m (→IHC) |
||
| Line 88: | Line 88: | ||
*CD45 -- +ve in NLPHL. | *CD45 -- +ve in NLPHL. | ||
*CD20 -- +ve in NLPHL. | *CD20 -- +ve in NLPHL. | ||
* | *BCL6. | ||
*MUM1<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/601900 http://www.ncbi.nlm.nih.gov/omim/601900]. Accessed on: 10 August 2010.</ref> -- -ve in NLPHL. | *MUM1<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/601900 http://www.ncbi.nlm.nih.gov/omim/601900]. Accessed on: 10 August 2010.</ref> -- -ve in NLPHL. | ||
*CD30 -- +ve in CHL. | *CD30 -- +ve in CHL (most sensitive). | ||
*CD15 -- +ve in CHL. | *CD15 -- +ve in CHL. | ||
*CD21 -- +ve in HLPHL. | *CD21 -- +ve in HLPHL. | ||
| Line 102: | Line 102: | ||
*EMA. | *EMA. | ||
*4 unstained. | *4 unstained. | ||
Notes: | |||
*NLPHL - usually surrounded by B cells. | |||
*CHL - usually surrounded by T cells. | |||
==See also== | ==See also== | ||